Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $10.78 Average Price Target from Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been given a consensus rating of “Moderate Buy” by the twelve research firms that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $10.7778.

Several research analysts have issued reports on AVAH shares. Truist Financial lifted their price target on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research report on Wednesday, June 3rd. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Finally, Barclays boosted their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th.

Aveanna Healthcare Stock Performance

NASDAQ:AVAH opened at $9.05 on Thursday. The company has a 50-day moving average of $8.77 and a 200-day moving average of $7.71. The firm has a market cap of $1.97 billion, a price-to-earnings ratio of 7.67, a price-to-earnings-growth ratio of 0.89 and a beta of 1.90. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. Aveanna Healthcare has a twelve month low of $5.93 and a twelve month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The business had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm’s revenue was up 15.9% compared to the same quarter last year. Analysts forecast that Aveanna Healthcare will post 0.68 earnings per share for the current fiscal year.

Insider Activity

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 3,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the transaction, the insider directly owned 190,130 shares in the company, valued at approximately $1,522,941.30. The trade was a 94.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the business’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total transaction of $19,376,470.35. Following the sale, the insider directly owned 10,112,123 shares in the company, valued at approximately $80,998,105.23. This trade represents a 19.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 31,305,664 shares of company stock worth $215,555,910 over the last three months. 5.30% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Landscape Capital Management L.L.C. purchased a new stake in Aveanna Healthcare in the 2nd quarter worth about $102,000. C M Bidwell & Associates Ltd. purchased a new position in Aveanna Healthcare during the 2nd quarter valued at about $69,000. NFJ Investment Group LLC purchased a new position in Aveanna Healthcare during the 2nd quarter valued at about $2,682,000. Virtus Advisers LLC purchased a new position in Aveanna Healthcare during the 2nd quarter valued at about $363,000. Finally, BlackRock Inc. acquired a new position in shares of Aveanna Healthcare in the 2nd quarter valued at about $63,504,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.